/Companies

Luminate

YC S21

Galway, US · Founded 2019 · 55 employees · 21 known investors

Find your way into Luminate

Sign up to see every warm intro you have to Luminate

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Luminate team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers. The company is advancing clinical-stage devices while supporting cancer patients, clinicians, and health systems.

Also known as Luminate Medical Inc. · Luminate Medical

Founders & leadership· Y Combinator alumni (S21)

Luminate was founded in 2019 by Aaron Hannon, Barbara Oliveira, and Prof. Martin O'Halloran.

AHAaron Hannon
Aaron HannonCEO & Co-FounderHe holds a background in software and electronic engineering and was a Thiel Fellow in 2020.
BOBarbara Oliveira
Barbara OliveiraCo-Founder & Chief Clinical OfficerBarbara Oliveira is a biomedical engineer and co-founder of Luminate Medical, a medical device company based in Galway, Ireland focused on cancer and chemotherapy patient support. She has led clinical trials for medical devices.
PMProf. Martin O'Halloran
Prof. Martin O'HalloranCo-FounderCo-founder of Luminate, which develops clinical-stage medical device technology to address chemotherapy side effects such as hair loss and peripheral neuropathy for oncology patients and healthcare providers.
JE
JAMES EVERINGHAMExecutive
EL
Eldad LivniFounder
LB
Leonid BelkindFounder
MO
Martin O'HalloranFounder
OS
Ofer SmadariFounder

Board

TF
TOD FRANCISBoard director
RL
ROBERT LISBONNEBoard director
SK
SAAD KHANBoard director
DS
DANNY SHADERBoard director

Investors · 21

Faberlisted by FaberLisbon · $108K – $2.7M

How we know: a partner's Signal profile · globenewswire.com · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Metaplanetlisted by MetaplanetTallinn · $500K – $10M

How we know: Metaplanet's portfolio page · the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

BateleurreportedCape Town

How we know: Y Combinator's founder network · Not right? Tell us

Elkstone Capital PartnersreportedDublin

How we know: Y Combinator's founder network · Not right? Tell us

Faber Capital SCR SAreportedLisbon · $2.7M

How we know: Y Combinator's founder network · Not right? Tell us

Harvard Management CompanyreportedAllston

How we know: Y Combinator's founder network · Not right? Tell us

Lachy Groomreported

How we know: globenewswire.com · Y Combinator's founder network · Not right? Tell us

LGF4reportedWest Hollywood

How we know: Y Combinator's founder network · Not right? Tell us

Lynett Capital PartnersreportedJupiter

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 1

Western Alliance Life Sciences

Funding

SEC filings, press & company announcements

$43.7M disclosed across 3 of 5 rounds · 2010–2026

▶$10.7MraisedFeb 2012 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • TOD FRANCISDirector
  • ROBERT LISBONNEExecutive Officer, Director
  • SAAD KHANDirector
  • JAMES EVERINGHAMExecutive Officer, Director
  • DANNY SHADERDirector
Offering amount
$12M
Amount sold
$10.7M
First sale
Dec 2011
Incorporated
Corporation, Delaware, 2007
Federal exemptions
06
Full filing on SEC EDGAR ↗
▶$12MraisedFeb 2012 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • DANNY SHADERDirector
  • JAMES EVERINGHAMExecutive Officer, Director
  • SAAD KHANDirector
  • ROBERT LISBONNEExecutive Officer, Director
  • JAMES WATSONDirector
Offering amount
$12M
Amount sold
$12M
First sale
May 2010
Incorporated
Corporation, Delaware, 2007
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 10

Luminate NYLuminate is an accelerator or startup support program that brings cohorts of deep-tech founders to New York City annually for investor meetings, industry feedback, and networking with established companies and research institutions.
Zeit MedicalZeit Medical develops a wearable headband with AI-powered sensors that detects strokes in real time and automatically alerts emergency services, targeting patients at high risk for stroke who may be asleep or unable to call for help themselves.
BlackbaudBlackbaud provides cloud software for social impact organizations — including nonprofits, schools, foundations, and companies — covering fundraising, financial management, grantmaking, corporate giving programs, and school administration. Its tools use a proprietary social impact dataset and AI to support donor prospecting, fund accounting, and grant lifecycle management.
iSono HealthiSono Health develops an automated ultrasound system combined with artificial intelligence for breast imaging at the point of care, enabling standardized and accessible imaging across different healthcare settings.
Luminate HealthLuminate Health provides a patient and provider engagement platform for clinical, anatomic pathology, specialty, and hospital labs, giving patients the ability to access, manage, and understand their lab results over time. The platform also supports direct-to-consumer testing, provider portals, and regulatory compliance (such as the ONC Cures Act) for labs across the United States.
NeodocsNeoDocs provides at-home health assessment tests with lab-quality accuracy and personalized health monitoring for consumers seeking preventive wellness. The company focuses on proactive health optimization rather than disease treatment.
eClinical SolutionseClinical Solutions provides software and services that give clients access to clinical trial data. It serves organizations conducting clinical trials in the life sciences industry.
Andromeda SurgicalAndromeda Surgical develops an AI-guided surgical platform that provides GPS-like navigation and autonomous task capabilities to surgeons, starting with endourology procedures. The platform integrates with existing surgical tools to assist interventional surgeons in performing procedures with enhanced precision and reduced training requirements.
HalluminateHalluminate provides reinforcement learning environments for financial services firms to train frontier AI models on workflows in investment banking, private equity, and consulting.
Atomic AlchemyAtomic Alchemy developed technology and facilities for producing radioisotopes for medical, industrial, and research applications, planning dedicated isotope-production reactors in Idaho. Acquired by Oklo in 2024.

Companies working in the same space as Luminate.

Legal entities · 1

corporate structure
Luminate Medical Inc.

In the news

Frequently asked questions

What does Luminate do?
Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers. The company is advancing clinical-stage devices while supporting cancer patients, clinicians, and health systems.
Who founded Luminate?
Luminate was founded by Aaron Hannon, Barbara Oliveira, Prof. Martin O'Halloran in 2019.
Who are Luminate's investors?
Luminate's investors include SciFounders, Y Combinator, 8VC, Artis Ventures, Atlantic Bridge Ventures, Faber, Gaingels, Metaplanet and 12 more.
How much funding has Luminate raised?
Luminate has disclosed $43.7M raised across 3 of its 5 known rounds.
Where is Luminate headquartered?
Luminate is headquartered in Galway, US.